chartexchange

DRTS
Alpha Tau Medical Ltd.
stockNASDAQ

Market OpenNov 19, 2026 2:39:02 PM EST
11.26USD-6.245%(-0.75)973,122
Pre-marketNov 19, 2026 9:27:30 AM EST
12.05USD+0.333%(+0.04)
11.11Bid11.33Ask0.22Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Jerusalem, Israel
Previous Close
$12.01
Beta
2.14
52-Week High
$15.79 2026-09-17
52-Week Low
$3.43 2025-11-21
SMA 50
$13.90
SMA 200
$10.99
Avg. Vol 10D
788,736
Avg. Vol 30D
597,135
Avg. Vol 90D
578,635
Relative Vol
1.60
64.10M
8.1800%
11,112
Nov 19, 2026 (today)
DRTS Profile

alpha tau medical (http://www.alphataumedical.com/) focuses on research, development and commercialization of alpha dart (diffusing alpha-emitters radiation therapy) for the treatment of solid cancer tumors. alpha dart technology, initially developed at tel aviv university, was shown to be effective and safe for treating different types of cancer in multiple animal studies. the company is running its first clinical trial in several sites in the eu. breakthrough technology for cancer treatment the alpha dart breakthrough technology utilizes alpha radiation to treat cancer and enables highly potent and conformal radiotherapy. alpha dart treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha emitting atoms into the tumor.

DRTS Performance
PeriodPriceDateChangeBeta
1W13.362026-11-12-15.57%6.106
1M12.622026-10-19-10.62%1.827
3M14.472026-08-19-22.05%1.731
6M10.682026-05-19+5.62%1.582
1Y3.682025-11-19+206.52%2.137
2Y2.302024-11-19+390.43%—
5Y9.132022-03-09+23.55%0.723
DRTS Stock Summary

Alpha Tau Medical Ltd. (NASDAQ:DRTS) stock price today is $11.28, and today's volume is 956,826. DRTS is down 6.080% today. The 30 day average volume is 597,135. DRTS market cap is $1.04B with 92.48M shares outstanding.